LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
about
LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
description
clinical trial
@en
klinisch onderzoek
@nl
name
LUX-Head&Neck 3: Afatinib (BIB ...... er Platinum Based Chemotherapy
@en
type
label
LUX-Head&Neck 3: Afatinib (BIB ...... er Platinum Based Chemotherapy
@en
prefLabel
LUX-Head&Neck 3: Afatinib (BIB ...... er Platinum Based Chemotherapy
@en
P17
P6153
P131
P1476
A Randomised, Open-label, Phas ...... After Platinum-based Therapy.
@en
P3098
NCT01856478
P4844
P580
2013-05-23T00:00:00Z
P582
2018-08-22T00:00:00Z